Cantor Fitzgerald Brokers Lower Earnings Estimates for JSPR
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a report issued on Wednesday, May 14th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will post earnings of ($4.52) per share for the year, down from their prior estimate of […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a report issued on Wednesday, May 14th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will post earnings of ($4.52) per share for the year, down from their prior estimate of […]
